中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

肝窦阻塞综合征患者行经颈静脉肝内门体分流术后死亡原因分析

凃晶晶 肖江强 张峰 诸葛宇征

引用本文:
Citation:

肝窦阻塞综合征患者行经颈静脉肝内门体分流术后死亡原因分析

DOI: 10.3969/j.issn.1001-5256.2020.12.022
基金项目: 

国家自然科学基金(81900552); 

详细信息
  • 中图分类号: R657.3

Causes of death after transjugular intrahepatic portosystemic shunt in patients with hepatic sinusoidal obstruction syndrome

Research funding: 

 

  • 摘要:

    目的分析肝窦阻塞综合征(HSOS)患者行经颈静脉肝内门体分流术(TIPS)后死亡的临床特点及原因,探讨进一步提高此类患者生存率的防治措施。方法回顾性分析2013年1月-2019年12月南京鼓楼医院收治的HSOS患者293例,其中行TIPS治疗后死亡20例,统计并分析20例患者的一般资料、实验室检查及临床治疗方案,比较病程不同阶段的指标变化及出现并发症等情况。正态分布的计量资料术前术后比较采用配对t检验;非正态分布的计量资料术前术后比较采用Wilcoxon秩和检验。结果20例死亡患者的平均生存时间为(15. 15±4. 21)周。其中男15例,女5例,平均年龄(67. 60±7. 01)岁,≥60岁患者17例(85%),90%以上的患者有腹胀、少尿等临床表现。9例(45%)合并慢性基础疾病,5例(25%)合并两种以上基础疾病。总体上,门静脉压力由术前的(21. 67±5. 15) mm Hg下降至术后的(8. 17±4. 98) mm Hg(t=10. 318,P<0. 05)。患者术前TBil、DBil、D-二聚体水平均明显高于正常值,术后5 d上述指标较术前仍有明显升高(Z值...

     

  • [1] ZHUGE Y,LIU Y,XIE W,et al. Expert consensus on the clinical management of pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome[J]. J Gastroenterol Hepatol,2019,34(4):634-642.
    [2] YANG XQ,YE J,LI X,et al. Pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome:Pathogenesis,clinical manifestations,diagnosis,treatment,and outcomes[J].World J Gastroenterol,2019,25(28):3753-3763.
    [3] DELEVE LD,SHULMAN HM,McDONALD GB. Toxic injury to hepatic sinusoids:Sinusoidal obstruction syndrome(veno-occlusive disease)[J]. Semin Liver Dis,2002,22(1):27-42.
    [4] Cooperative Group for Hepatic and Gall Diseases,Chinese Society of Gastroenterology, Chinese Medical Association.Expert consensus on diagnosis and treatment of quinazoline alkaloids-related sinusoidal obstruction syndrome(2017,Nanjing)[J]. J Clin Hepatol,2017,33(9):1627-1637.(in Chinese)中华医学会消化病学分会肝胆疾病协作组.吡咯生物碱相关肝窦阻塞综合征诊断和治疗专家共识意见(2017年,南京)[J].临床肝胆病杂志,2017,33(9):1627-1637.
    [5] BOYER TD. Transjugular intrahepatic portosystemic shunt:Current status[J]. Gastroenterology,2003,124(6):1700-1710.
    [6] LIU ZL,FAN ZP,GOU YS,et al. Clinical features,pathogenesis,and diagnosis and treatment of different types of hepatic sinusoidal obstruction syndrome[J]. J Clin Hepatol,2019,35(1):208-212.(in Chinese)刘贞利,范作鹏,勾钰淞,等.不同类型肝窦阻塞综合征的临床特征、发病机制与诊治[J].临床肝胆病杂志,2019,35(1):208-212.
    [7] ROEKER LE,KIM HT,GLOTZBECKER B,et al. Early clinical predictors of hepatic veno-occlusive disease/sinusoidal obstruction syndrome after myeloablative stem cell transplantation[J]. Biol Blood Marrow Transplant,2019,25(1):137-144.
    [8] GAO H,LI N,WANG JY,et al. Definitive diagnosis of hepatic sinusoidal obstruction syndrome induced by pyrrolizidine alkaloids[J]. J Dig Dis,2012,13(1):33-39.
    [9] CRAWFORD MJ. Vascular disorders of the liver[J]. Clin Liver Dis,2010,14(4):635-650.
    [10] LIN G,WANG JY,LI N,et al. Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum[J]. J Hepatol,2011,54(4):666-673.
    [11] ZHUGE YZ,WANG Y,ZHANG F,et al. Clinical characteristics and treatment of pyrrolizidine alkaloid-related hepatic vein occlusive disease[J]. Liver Int,2018,38(10):1867-1874.
    [12] CHOJKIER M. Hepatic sinusoidal-obstruction syndrome:Toxicity of pyrrolizidine alkaloids[J]. J Hepatol,2003,39(3):437-446.
    [13] CORBACIOGLU S,CESARO S,FARACI M,et al. Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation:An open-label,phase 3,randomised controlled trial[J]. Lancet,2012,379(9823):1301-1309.
    [14] PENG C,ZHANG X,ZHANG F,et al. Clinical efficacy and safety of anticoagulation therapy for Pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome:A retrospective multicenter cohort study[J]. Eur J Gastroenterol Hepatol,2020,32(9):1168-1178.
    [15] WANG Y,QIAO D,LI Y,et al. Risk factors for hepatic venoocclusive disease caused by Gynura segetum:A retrospective study[J]. BMC Gastroenterol,2018,18(1):156.
  • 加载中
计量
  • 文章访问数:  4394
  • HTML全文浏览量:  42
  • PDF下载量:  84
  • 被引次数: 0
出版历程
  • 收稿日期:  2020-07-01
  • 出版日期:  2020-12-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回